Conference Information: There needs to be a fundamental shift in drug discovery and artificial Intelligence holds the key to bringing the pharma industry into the 21st Century. From discovery and development and through the entire product lifecycle, artificial intelligence (AI) is starting to shake up the life-sciences industry. The potential of intelligent apps (i.e., apps that are capable of learning from experience) is so far-reaching that it is expected that AI-enabled drugs will be brought to market in the near future. A Silicon Valley Bank analysis last month found that 44 venture-backed deals raised $2.2 billion between 2015 and the first half of 2017 for Dx/Tools companies that use AI/ML as part of their underlying technology. A report from Aruba states that 60 percent of health care organizations across the world have started using the internet of things in their facilities. Current uses include insulin delivery, activity trackers for cancer treatment, ingestible sensors, depression-fighting apps, and more. A growing need for healthier lifestyles coupled with breakthrough technological innovation has been instrumental in boosting adoption, and the global IoT healthcare market is expected to grow from USD32.4 Bn in 2015 to USD163.2 Bn by 2020, a CAGR of 38.1%. One of the world's biggest markets for healthcare services, the United States spends approximately 18% of its GDP on healthcare every year. By improving adherence to prescribed therapies alone, the US could significantly reduce their healthcare spends. The effective deployment of IoT-based healthcare delivery technologies could help the US save well over USD 300 billion Our Pharma AI & IoT 2018 will provide insight into the current state of play in the EU & US and stimulate debate, in a multi-stakeholder setting, on the vital role of techonologyy impact in the sustainability of pharma and healthcare systems. Beyond a comprehensive outlook of key European market access policies, our speakers will outline the key recent developments in technology impact in pharma and healthcare in the EU and other international jurisdictions. By attending this conference, you will gain a comprehensive outlook on the key issues surrounding latest technologies that are being analysed towards the pharma and healthcare. This event will provide an important platform for stakeholders to discuss and share best practices in furthering technology development in pharma and healthcare It gives me great pleasure in welcoming all of you to the Virtue Insight's Pharma AI & IoT 2018.
Key Speakers:
Key Themes
Why Should You Sponsor: Virtue Insight Conferences and events offer commercial organisations and partners a wide range of opportunities to promote their products and services at our events during the calendar year! All of our Virtue Insight sponsorship opportunities are tailored to your requirements and we provide a number of flexible packages that will meet your company's marketing objectives. Sponsorship can be used in a number of ways to increase your brand and product awareness in both a highly targeted and clutter free environment. Partnering with Virtue Insight allows you to showcase your brand and product in a professional and independent setting, when our delegates are in a receptive and engaging mindset. Our experts will work with you and your team, to create real added value to any campaign and we welcome the opportunity to discuss your requirements in detail. Furthermore, Virtue Insight has a hard earned reputation for forming strong, long standing and valuable partnerships with our sponsors and we will work hard to deliver your campaign, on time and on budget! Benifits of Sponsorship: Who Should Attend: CIOs, CEOs, CDOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, Evangelists and Senior Scientists from the following area:
Why Should You Attend:
Pharma AI & IoT 2018 – "Integrating AI, IoT, Cloud & Big Data Analytics in Pharma & Healthcare" Get more from the event, enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference. Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway. Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margins.
Conference Booking Details: Super Early Bird Pricing (till 08-May-2018) : £600 + VAT Per Delegate Super Early Bird Pricing (till 08-May-2018) : £1200 + VAT (3 Delegates at price of 2) for 3 Delegates You can simply email and book your conference delegate seats Conference Sponsor & Exhibition Space – Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to saket@viconferences.co.uk Registration process To register simply email the below mentioned details to saket@viconferences.co.uk Company:
Unable to attend: Obviously nothing compares to being there but you not need to miss out. Simply send the above information for getting a copy of all speakers's presentation slides and other materials that will come out of the conference for Just £400. Please contact me if you have any ruther questions I look forward to hearing from you. Kind Regards Saket Vayeda Events Manager
To Unsubscribe send an email with Unsubscribe in the subject line to info@viconferences.com |
Комментариев нет:
Отправить комментарий